These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6795061)

  • 1. Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor VIIa and tissue factor.
    Carson SD
    FEBS Lett; 1981 Sep; 132(1):37-40. PubMed ID: 6795061
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence that plasma lipoproteins inhibit the factor VIIa-tissue factor complex by a different mechanism that extrinsic pathway inhibitor.
    Kondo S; Kisiel W
    Blood; 1987 Dec; 70(6):1947-54. PubMed ID: 3315045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary procoagulant behaves as tissue factor by promoting factor VIIa-catalyzed activation of factor X.
    Kurosawa S; Matsuda M; Aoki N
    Thromb Res; 1984 Mar; 33(6):595-606. PubMed ID: 6609450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of lipoproteins on the tissue factor-dependent activation of factor X.
    Trimarchi A; Minestrini D; Palazzesi G; Cassetti M
    Int J Clin Lab Res; 1992; 22(2):115-8. PubMed ID: 1504304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor (coagulation factor III) inhibition by apolipoprotein A-II.
    Carson SD
    J Biol Chem; 1987 Jan; 262(2):718-21. PubMed ID: 3100517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activation of factor X and factor X beta with factor VII or protein M.
    Seegers WH; Ghosh A
    Thromb Res; 1980 Feb 1-15; 17(3-4):501-6. PubMed ID: 6989015
    [No Abstract]   [Full Text] [Related]  

  • 7. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.
    Novotny WF; Girard TJ; Miletich JP; Broze GJ
    J Biol Chem; 1989 Nov; 264(31):18832-7. PubMed ID: 2553722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lipid-binding proteins apo A-I, apo A-IL, beta 2-glycoprotein I, and C-reactive protein on activation of factor X by tissue factor--factor VIIa.
    Carson SD; Ross SE
    Thromb Res; 1988 Jun; 50(5):669-78. PubMed ID: 3137684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administration.
    Kjalke M; Oliver JA; Monroe DM; Hoffman M; Ezban M; Hedner U; Roberts HR
    Thromb Haemost; 1997 Oct; 78(4):1202-8. PubMed ID: 9364985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow as a regulator of the activation of factor X by tissue factor.
    Gemmell CH; Turitto VT; Nemerson Y
    Blood; 1988 Oct; 72(4):1404-6. PubMed ID: 3262388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of 125I-factor IX and 125I-factor X: effect of tissue factor and factor VII, factor Xa and thrombin.
    Osterud B; Rapaport SI
    Scand J Haematol; 1980 Mar; 24(3):213-26. PubMed ID: 7375819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow dependence of factor X activation by tissue factor-factor VIIa.
    Contino PB; Andree HA; Nemerson Y
    J Physiol Pharmacol; 1994 Mar; 45(1):81-90. PubMed ID: 8043911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein.
    Girard TJ; MacPhail LA; Likert KM; Novotny WF; Miletich JP; Broze GJ
    Science; 1990 Jun; 248(4961):1421-4. PubMed ID: 1972598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects.
    de Jonge E; Friederich PW; Vlasuk GP; Rote WE; Vroom MB; Levi M; van der Poll T
    Clin Diagn Lab Immunol; 2003 May; 10(3):495-7. PubMed ID: 12738659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
    Hoffman M; Monroe DM
    Dis Mon; 2003 Jan; 49(1):14-21. PubMed ID: 12525825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of activated coagulation factor VII by normal human plasma.
    Dahl PE; Abildgaard U; Larsen ML; Tjensvoll L
    Thromb Haemost; 1982 Dec; 48(3):253-6. PubMed ID: 7164015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The factor VIII-independent activation of factor X by factors IXa and VII in plasma.
    Ofosu F; Blajchman MA; Modi G; Hirsh J
    Thromb Res; 1981 Jan 1-15; 21(1-2):23-33. PubMed ID: 6785896
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on experimentally induced hypercoagulable state in rabbits.
    Izak G; Galewsky K
    Thromb Diath Haemorrh; 1966 Jul; 16(1):228-42. PubMed ID: 5989043
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of factor VII in the intrinsic pathway: a brief review.
    Prydz H
    Haemostasis; 1983; 13(3):156-60. PubMed ID: 6350120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component.
    Sanders NL; Bajaj SP; Zivelin A; Rapaport SI
    Blood; 1985 Jul; 66(1):204-12. PubMed ID: 3873968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.